Runner's High Has an Endocannabinoid Signature in Humans. Dogs Show It Too.
Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'
In lab treadmill tests, high-intensity running was linked to higher blood endocannabinoids in humans and dogs, but not in ferrets and not during easy walking.
For decades, the story was simple: you run hard, your body releases endorphins, you feel euphoric. The "runner's high" was an endorphin phenomenon. Case closed.
There was just one problem. Endorphins are large peptide molecules. They're too big to cross the blood-brain barrier. If running releases endorphins into your bloodstream — which it does — those endorphins can't reach the brain regions where euphoria is generated. The timeline didn't work either: endorphin levels peak after exercise stops, but the runner's high typically arrives during the effort.
Something else was responsible. In 2012, an anthropologist at the University of Arizona figured out what.
The Right Question
David Raichlen wasn't a neuroscientist. He was a biological anthropologist studying human evolution. His research question wasn't "what causes euphoria during exercise?" — it was "why do humans run at all?"
From an evolutionary standpoint, running is expensive. It burns enormous calories, risks injury, and stresses joints. Most mammals avoid sustained running unless they're chasing prey or fleeing predators. But humans voluntarily run — for exercise, for pleasure, for no immediate survival reason. So do dogs. Horses do too. These species are "cursorial" — anatomically adapted for endurance running.
Raichlen's hypothesis: cursorial mammals evolved a neurobiological reward system that makes running feel good, encouraging the sustained locomotion that their bodies were built for. And the reward system wasn't endorphins — it was endocannabinoids.
The Experiment
The Results
The pattern was exactly what the evolutionary hypothesis predicted. Humans and dogs — species built for endurance — got an endocannabinoid surge from running. Ferrets — a species built for short, explosive bursts — didn't. And crucially, the reward was intensity-dependent: walking didn't trigger it. You had to run.
Why This Matters for Cannabis Users
The Endorphin Myth
Myth vs. Reality
The runner's high is caused by endorphins.
Endorphins are released during exercise, but they're too large to cross the blood-brain barrier — they can't reach the brain circuits where euphoria is generated. Endocannabinoids (especially anandamide) are small lipid molecules that cross the blood-brain barrier easily and activate reward-related CB1 receptors in the brain. The runner's high is primarily an endocannabinoid phenomenon, not an endorphin one.
The Evidence
Raichlen et al. (2012) showed exercise-induced endocannabinoid increases in cursorial mammals. A 2015 mouse study (Fuss et al., PNAS) directly demonstrated that blocking cannabinoid receptors eliminated the runner's high in mice, while blocking opioid receptors did not. The endocannabinoid hypothesis has now largely replaced the endorphin explanation in the scientific literature.
Raichlen et al. (2012), J Exp Biol; Fuss et al. (2015), PNAS 112:13105-13108
The endorphin story persisted for decades because it was elegant and intuitive — "natural opioids make you feel good." But the pharmacology never fully supported it. The 2015 Fuss et al. mouse study provided the definitive test: mice with blocked cannabinoid receptors lost the runner's high; mice with blocked opioid receptors kept it. The endocannabinoid system, not the opioid system, is the primary driver.
An Evolutionary Perspective
Raichlen's genius was in framing the question evolutionarily. He wasn't asking "what neurotransmitter does exercise release?" — a pharmacology question. He was asking "why do certain species choose to run?" — an evolutionary question. The endocannabinoid reward provides an answer: cursorial mammals evolved a neurobiological incentive to engage in the locomotor behavior their bodies were designed for.
Humans are running animals. Our anatomy — long legs, short toes, nuchal ligament, sweat cooling, Achilles tendons — is built for endurance running. But anatomy alone doesn't guarantee behavior. You need motivation. The endocannabinoid reward system provides it: run hard enough, and your brain produces its own cannabis-like euphoria.
From this perspective, the modern epidemic of sedentary behavior represents an evolutionary mismatch. We have the hardware for running and the neurochemical reward system to encourage it — but we've built environments where running is optional. The endocannabinoid system that evolved to reward locomotion now goes understimulated.
Limitations
This study was small, measured only blood biomarkers (not brain activity), and didn't collect mood or euphoria ratings. It showed that endocannabinoids increase with running intensity in cursorial mammals — it didn't prove that those endocannabinoids cause the subjective experience of the runner's high. The 2015 Fuss et al. mouse study later provided that causal evidence.
The blood-brain inference — that rising blood endocannabinoids indicate rising brain endocannabinoids — is reasonable but not proven for exercise specifically. Anandamide does cross the blood-brain barrier, but blood levels and brain levels don't always track perfectly.
Frequently Asked Questions
Cite this study
Raichlen, David A.; Foster, Adam D.; Gerdeman, Gregory L.; Seillier, Alexandre; Giuffrida, Andrea. (2012). Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. Journal of Experimental Biology, 215(8), 1331-1336. https://doi.org/10.1242/jeb.063677